Breast Implant-Associated Anaplastic Large Cell Lymphoma: My Personal Journey
The objective of this article is to bring awareness to health care professionals about BIA-ALCL, provide a brief history of the United States Food and Drug Administration textured breast implant approvals and subsequent recall, and talk about the emotional rollercoaster this diagnosis brings to the patient.
Source: Plastic Surgical Nursing - Category: Nursing Tags: Articles Source Type: research
More News: Breast Augmentation | Cancer | Cancer & Oncology | Food and Drug Administration (FDA) | Health Management | Lymphoma | Nurses | Nursing | Plastic Surgery | USA Health